Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 111

1.

Direct head-to-head comparison of cationic liposome-mediated gene delivery to mesenchymal stem/stromal cells of different human sources: a comprehensive study.

Boura JS, Santos FD, Gimble JM, Cardoso CM, Madeira C, Cabral JM, Silva CL.

Hum Gene Ther Methods. 2013 Feb;24(1):38-48. doi: 10.1089/hgtb.2012.185.

2.

Nonviral gene delivery to mesenchymal stem cells using cationic liposomes for gene and cell therapy.

Madeira C, Mendes RD, Ribeiro SC, Boura JS, Aires-Barros MR, da Silva CL, Cabral JM.

J Biomed Biotechnol. 2010;2010:735349. doi: 10.1155/2010/735349. Epub 2010 Jun 24.

3.

The umbilical cord matrix is a better source of mesenchymal stem cells (MSC) than the umbilical cord blood.

Zeddou M, Briquet A, Relic B, Josse C, Malaise MG, Gothot A, Lechanteur C, Beguin Y.

Cell Biol Int. 2010 Jul;34(7):693-701. doi: 10.1042/CBI20090414.

PMID:
20187873
4.

Human mesenchymal stem cells from the umbilical cord matrix: successful isolation and ex vivo expansion using serum-/xeno-free culture media.

Simões IN, Boura JS, dos Santos F, Andrade PZ, Cardoso CM, Gimble JM, da Silva CL, Cabral JM.

Biotechnol J. 2013 Apr;8(4):448-58. doi: 10.1002/biot.201200340. Epub 2013 Mar 7.

PMID:
23420807
5.

ScreenFect A: an efficient and low toxic liposome for gene delivery to mesenchymal stem cells.

Li LM, Ruan GX, HuangFu MY, Chen ZL, Liu HN, Li LX, Hu YL, Han M, Davidson G, Levkin PA, Gao JQ.

Int J Pharm. 2015 Jul 5;488(1-2):1-11. doi: 10.1016/j.ijpharm.2015.04.050. Epub 2015 Apr 17.

PMID:
25895721
6.
7.

[Basic biological characteristics of mesenchymal stem cells derived from bone marrow and human umbilical cord].

Han ZX, Shi Q, Wang DK, Li D, Lyu M.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2013 Oct;21(5):1248-55. doi: 10.7534/j.issn.1009-2137.2013.05.033. Chinese.

PMID:
24156444
8.

Comparison of human mesenchymal stem cells derived from dental pulp, bone marrow, adipose tissue, and umbilical cord tissue by gene expression.

Stanko P, Kaiserova K, Altanerova V, Altaner C.

Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2014 Sep;158(3):373-7. doi: 10.5507/bp.2013.078. Epub 2013 Oct 18.

9.

Small RNA and RNA-IP Sequencing Identifies and Validates Novel MicroRNAs in Human Mesenchymal Stem Cells.

Tsai CH, Liao KH, Shih CC, Chan CH, Hsieh JY, Tsai CF, Wang HW, Chang SJ.

OMICS. 2016 Mar;20(3):191-8. doi: 10.1089/omi.2015.0136. Epub 2016 Feb 24.

PMID:
26910904
10.

Human stromal (mesenchymal) stem cells from bone marrow, adipose tissue and skin exhibit differences in molecular phenotype and differentiation potential.

Al-Nbaheen M, Vishnubalaji R, Ali D, Bouslimi A, Al-Jassir F, Megges M, Prigione A, Adjaye J, Kassem M, Aldahmash A.

Stem Cell Rev. 2013 Feb;9(1):32-43. doi: 10.1007/s12015-012-9365-8.

11.

Enhanced neuro-therapeutic potential of Wharton's Jelly-derived mesenchymal stem cells in comparison with bone marrow mesenchymal stem cells culture.

Drela K, Lech W, Figiel-Dabrowska A, Zychowicz M, Mikula M, Sarnowska A, Domanska-Janik K.

Cytotherapy. 2016 Apr;18(4):497-509. doi: 10.1016/j.jcyt.2016.01.006.

PMID:
26971678
12.

Polyethylenimine-mediated gene delivery into human bone marrow mesenchymal stem cells from patients.

Wang W, Li W, Ou L, Flick E, Mark P, Nesselmann C, Lux CA, Gatzen HH, Kaminski A, Liebold A, Lützow K, Lendlein A, Li RK, Steinhoff G, Ma N.

J Cell Mol Med. 2011 Sep;15(9):1989-98. doi: 10.1111/j.1582-4934.2010.01130.x. Epub 2010 Jul 13.

13.

Optimizing viral and non-viral gene transfer methods for genetic modification of porcine mesenchymal stem cells.

Stiehler M, Duch M, Mygind T, Li H, Ulrich-Vinther M, Modin C, Baatrup A, Lind M, Pedersen FS, Bünger CE.

Adv Exp Med Biol. 2006;585:31-48.

PMID:
17120775
14.

Lentiviral vectors for sustained transgene expression in human bone marrow-derived stromal cells.

Zhang XY, La Russa VF, Bao L, Kolls J, Schwarzenberger P, Reiser J.

Mol Ther. 2002 May;5(5 Pt 1):555-65.

15.

New emerging potentials for human Wharton's jelly mesenchymal stem cells: immunological features and hepatocyte-like differentiative capacity.

Anzalone R, Lo Iacono M, Corrao S, Magno F, Loria T, Cappello F, Zummo G, Farina F, La Rocca G.

Stem Cells Dev. 2010 Apr;19(4):423-38. doi: 10.1089/scd.2009.0299. Review.

PMID:
19958166
16.

Lentiviral vector mediated modification of mesenchymal stem cells & enhanced survival in an in vitro model of ischaemia.

McGinley L, McMahon J, Strappe P, Barry F, Murphy M, O'Toole D, O'Brien T.

Stem Cell Res Ther. 2011 Mar 7;2(2):12. doi: 10.1186/scrt53.

18.

Distinct differentiation potential of "MSC" derived from cord blood and umbilical cord: are cord-derived cells true mesenchymal stromal cells?

Bosch J, Houben AP, Radke TF, Stapelkamp D, Bünemann E, Balan P, Buchheiser A, Liedtke S, Kögler G.

Stem Cells Dev. 2012 Jul 20;21(11):1977-88. doi: 10.1089/scd.2011.0414. Epub 2012 Jan 4.

PMID:
22087798
19.

Differentiation of umbilical cord mesenchymal stem cells into steroidogenic cells in comparison to bone marrow mesenchymal stem cells.

Wei X, Peng G, Zheng S, Wu X.

Cell Prolif. 2012 Apr;45(2):101-10. doi: 10.1111/j.1365-2184.2012.00809.x. Epub 2012 Feb 13.

PMID:
22324479
20.

Long-term expansion and pluripotent marker array analysis of Wharton's jelly-derived mesenchymal stem cells.

Nekanti U, Rao VB, Bahirvani AG, Jan M, Totey S, Ta M.

Stem Cells Dev. 2010 Jan;19(1):117-30. doi: 10.1089/scd.2009.0177.

PMID:
19619003

Supplemental Content

Support Center